Brentuximab-vedotin consists of an antibody (brentuximab) and a chemotherapy drug linked together. The antibody helps deliver the chemotherapy drug more specifically to cancer cells, to fight against them.
Allergic reaction may occur. Please alert the nurse if you experience any of the following symptoms during infusion: itch, rashes, fever, chills, shivering or shortness of breath.
Inform your doctor if any of the following occurs:
Subcribe to our mailing list to get the updates to your email inbox...
Best viewed on IE 11, Firefox 27, Chrome 22, and Safari 7 and above.